John Myung-Jae Cho

Title: John Myung-Jae Cho: Innovator in Cancer Research

Introduction

John Myung-Jae Cho is a prominent inventor based in Westmount, Canada. He has made significant contributions to the field of cancer research through his innovative work on transcriptional factors. His research focuses on the mechanisms of gene regulation, particularly in the context of neoplastic disorders.

Latest Patents

John Myung-Jae Cho holds a patent for a groundbreaking invention titled "Replication protein A binding transcriptional factor (RBT1) and uses thereof." This invention relates to replication protein A (RPA) transcriptional factors. The patent provides a nucleotide sequence encoding a replication protein A transcriptional activator 1 (RTB1) and a protein encoded by such a nucleotide sequence. RBT1 exhibits high activity and is highly transactivated in cancer cells. The sequence may be utilized to treat neoplastic disorders and in gene therapy. He has 1 patent to his name.

Career Highlights

John Myung-Jae Cho is affiliated with the Center for Translation Research in Cancer, where he conducts his research. His work has been instrumental in advancing our understanding of cancer biology and potential therapeutic approaches.

Collaborations

John collaborates with Moulay Alaoui-Jamali, contributing to the innovative research environment at the Center for Translation Research in Cancer.

Conclusion

John Myung-Jae Cho is a dedicated inventor whose work in cancer research has the potential to impact treatment strategies significantly. His contributions to the field are noteworthy and continue to inspire further research and innovation.